Sign up to save your podcasts
Or
Share Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients
The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
View all episodes
By American Thoracic Society
4.1
3333 ratings
The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
More shows like Out of the Blue: An AJRCCM Podcast
View all
JAMA Editors' Summary
133 Listeners
EMCrit FOAM Feed
1,869 Listeners
NEJM This Week
314 Listeners
CHEST Journal Podcasts
62 Listeners
Core EM - Emergency Medicine Podcast
248 Listeners
JAMA Clinical Reviews
492 Listeners
The Curbsiders Internal Medicine Podcast
3,325 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Annals On Call Podcast
191 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Run the List
248 Listeners
Critical Care Scenarios
251 Listeners
The Curious Clinicians
365 Listeners
Critical Care Time
237 Listeners